[{"id":"d948359a-26a5-4f19-8293-b4a4c5ac0bcd","acronym":"","url":"https://clinicaltrials.gov/study/NCT01259479","created_at":"2021-01-18T05:04:50.613Z","updated_at":"2024-07-02T16:37:09.219Z","phase":"Phase 1","brief_title":"Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors","source_id_and_acronym":"NCT01259479","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" AFP","pipe":"","alterations":" ","tags":["AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • Orplatna (satraplatin)"],"overall_status":"Completed","enrollment":" Enrollment 9","initiation":"Initiation: 12/03/2010","start_date":" 12/03/2010","primary_txt":" Primary completion: 08/01/2013","primary_completion_date":" 08/01/2013","study_txt":" Completion: 05/29/2015","study_completion_date":" 05/29/2015","last_update_posted":"2018-07-05"},{"id":"62f11ef5-b612-4d5f-abd8-ff976f0d44d9","acronym":"","url":"https://clinicaltrials.gov/study/NCT01289067","created_at":"2021-01-18T05:14:05.746Z","updated_at":"2024-07-02T16:37:13.933Z","phase":"Phase 2","brief_title":"Utilizing A Genomic Sig for \"BRCAness\" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca","source_id_and_acronym":"NCT01289067","lead_sponsor":"William K. Oh","biomarkers":" BRCA","pipe":"","alterations":" ","tags":["BRCA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e docetaxel • Orplatna (satraplatin)"],"overall_status":"Completed","enrollment":" Enrollment 13","initiation":"Initiation: 12/01/2010","start_date":" 12/01/2010","primary_txt":" Primary completion: 05/01/2013","primary_completion_date":" 05/01/2013","study_txt":" Completion: 05/01/2013","study_completion_date":" 05/01/2013","last_update_posted":"2018-02-13"}]